本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

3.55
+0.24007.25%
盘后3.620.0694+1.95%19:52 EDT
成交量:19.98万
成交额:71.07万
市值:6,225.26万
市盈率:-2.79
高:3.73
开:3.40
低:3.29
收:3.31
数据加载中...
2021/02/05

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/05

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/29

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

重要事件披露

8-K - Current report
2020/12/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/24

重要事件披露

8-K - Current report